Brett Smith, MD
Ophthalmology · Concord, NHNPI 1689939795
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $200 of the $237 with a category attached, or 84.5%. 7 manufacturers reported payments, led by RMR Ortho Inc at 40.5% of the total. 2025 is the largest year on record at $96, 2.6 times the $37 reported in 2020. That places this record below the midpoint for ophthalmology clinicians in NH, where the typical reported total is $750.
Across 8 payments — averaging $29.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- RMR Ortho Inc$96
- Alcon$40
- Bausch & Lomb Americas Inc.$25
- Rayner Intraocular Lenses Limited$21
- Carl Zeiss Meditec AG$19
- AbbVie$19
- plus $17 from 1 others
What the payments were for
- Food & beverage$20085%
- Gifts$3715%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| RMR Ortho Inc | 1 | $96 |
| Alcon | 2 | $40 |
| Bausch & Lomb Americas Inc. | 1 | $25 |
| Rayner Intraocular Lenses Limited | 1 | $21 |
| Carl Zeiss Meditec AG | 1 | $19 |
| AbbVie | 1 | $19 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
How this compares
$237 in reported general payments places this provider in the 30th percentile of 80 ophthalmology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 44 | $37,457 |
| Bromfenac Sodium | 203 | $22,223 |
| Prednisolone Acetate | 356 | $14,361 |
| Cyclosporine | 39 | $13,018 |
| Ofloxacin | 409 | $3,601 |
| Latanoprost | 188 | $1,522 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 52 | $1,053 |
| Timolol Maleate | 66 | $868 |
| Travoprost | 11 | $563 |
| Doxycycline Hyclate | 14 | $497 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 17 | $193 |
| ErythromycinErythromycin Base | 24 | $189 |
| Brimonidine Tartrate | 21 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $19 | $37,45744 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 80 ophthalmology providers in New Hampshire.
Other ophthalmology in Concord
- Christie MorseConcord$6K
- Erin FogelConcord$4K
- Jerome Ramos-EstebanConcord$3K
- Tighe RichardsonConcord$2K
- Purvi ShahConcord$638
- Maxwell SneadConcord$397
- Catherine MarandoConcord$288
- Bradford HallConcord$202
- Dane SlentzDerry$127K
- Jason SzelogPortsmouth$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.